About Helperby Therapeutics
Helperby Therapeutics is a spin-out drug discovery company from St George’s University of London and has been working for the last 12 years developing antibiotics that specifically target dormant bacteria, a technique that has never been done before. This pioneering discovery by Professor Anthony Coates and Dr Yanmin Hu is a unique, patented approach that has shown real promise in early studies in breaking resistance when Helperby’s compounds are combined with old.
Facts about Helperby Therapeutics
Facts about Helperby Therapeutics
- Focus : Manufacturer
- Industry : Pharma
Here you will find Helperby Therapeutics
Last viewed contents
Involuntary_commitment
BBCH-scale_(rice)
Translational Centre for Regenerative Medicine (TRM-Leipzig) - Leipzig, Germany
BBCH-scale_(leafy_vegetables_forming_heads)
BBCH-scale_(citrus)
Bioform Technologies - Vancouver, BC, Canada
Nanoparticle Assembly Enters the Fast Lane - Method borrows instructions from molecular code of life
Novartis powers-up R&D with new Intel-based PC computing grid - Pharmaceutical giant refreshes IT infrastructure to speed drug development cycle and enhance operational efficiency
BBCH-scale_(sunflower)
Dipl.-Ing. Wilhelm Schmidt GmbH - Seeheim-Jugenheim, Germany
CEA - Centre de Saclay - Gif-sur-Yvette, France
